Shanghai Newsummit Biopharma Group Co., Ltd

About Shanghai Newsummit Biopharma Group Co., Ltd

Established in Shanghai in 2001, Newsummit Biopharma is committed to accelerating the translation of healthcare innovations into clinically relevant products and services, for the benefit of patients in China and the world. Via its unique Collaborative Healthcare Organization (CHO) services model, Newsummit Biopharma leverages clinical, scientific, industrial, governmental and financial resources globally to create a unique, patient-centric healthcare product development ecosystem rooted in innovation. Newsummit Biopharma is a wholly owned subsidiary of Zhejiang Yatai Pharmaceuticals, a Chinese listed pharmaceutical company (SHE:002370) focused on the fight against infectious diseases.
YEAR FOUNDED:
2001
LEADERSHIP:
CEO: Jun Ren
CLINICAL TRIAL:
Please click here for clinical trial information.